This activity is expired and is no longer available for CME credit.


Emerging Therapies and Targets for Progressive Multiple Sclerosis

Author(s)/Faculty: Clyde E. Markowitz, MD
Release Date: 12/16/2016Expiration Date: 12/15/2017
Credit Type: CME / CNENumber of Credits: 0
Content Type: ArticleProvider:
The past several decades have seen tremendous progress in the treatment of relapsing-remitting multiple sclerosis (MS). In contrast, the treatment of progressive MS remains challenging. Improved understanding of the underlying biology of disease progression has led to the identification of therapeutic targets and potential new treatments. This activity will summarize the clinical trial evidence on emerging therapies for progressive MS to help clinicians integrate these agents effectively into future treatment regimens.